Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Roivant Sciences (ROIV) Non-Current Assets (2021 - 2025)

Roivant Sciences' Non-Current Assets history spans 5 years, with the latest figure at $565.5 million for Q4 2025.

  • For Q4 2025, Non-Current Assets fell 75.84% year-over-year to $565.5 million; the TTM value through Dec 2025 reached $1.9 billion, down 17.2%, while the annual FY2025 figure was $202000.0, 98.6% down from the prior year.
  • Non-Current Assets reached $565.5 million in Q4 2025 per ROIV's latest filing, up from $551.0 million in the prior quarter.
  • In the past five years, Non-Current Assets ranged from a high of $2.3 billion in Q4 2024 to a low of $202000.0 in Q1 2025.
  • Average Non-Current Assets over 5 years is $618.6 million, with a median of $512.9 million recorded in 2021.
  • Peak YoY movement for Non-Current Assets: skyrocketed 257.11% in 2023, then plummeted 98.6% in 2025.
  • A 5-year view of Non-Current Assets shows it stood at $511.8 million in 2021, then rose by 8.77% to $556.7 million in 2022, then surged by 257.11% to $2.0 billion in 2023, then grew by 17.73% to $2.3 billion in 2024, then plummeted by 75.84% to $565.5 million in 2025.
  • Per Business Quant, the three most recent readings for ROIV's Non-Current Assets are $565.5 million (Q4 2025), $551.0 million (Q3 2025), and $416.9 million (Q2 2025).